Neuroone Medical Technologies (NMTC) Share-based Compensation (2017 - 2026)
Neuroone Medical Technologies (NMTC) posted Share-based Compensation of $342135.0 for Q1 2026, down 86.41% on a QoQ basis from $2.5 million in Q4 2025, and up 36.76% year-over-year from $250170.0 in Q1 2025.
Neuroone Medical Technologies (NMTC) Share-based Compensation (2017 - 2026) Analysis & Trends
Neuroone Medical Technologies' Share-based Compensation history runs 10 years deep, the most recent figure standing at $342135.0 for Q1 2026.
- Quarterly Share-based Compensation rose 36.76% year-over-year to $342135.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (up 21.75% YoY) and the FY2025 annual result came in at $2.9 million, up 20.88% from the prior year.
- Share-based Compensation was $342135.0 for Q1 2026 at Neuroone Medical Technologies, down from $2.5 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $2.5 million in Q4 2025 and bottomed at -$736675.0 in Q3 2023.
- A 5-year average of $357874.8 and a median of $300181.0 in 2022 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2023 — Share-based Compensation tumbled 387.9% — and 2025, when it surged 2150.53%.
- Neuroone Medical Technologies' Share-based Compensation stood at $300181.0 in 2022, then climbed by 2.82% to $308638.0 in 2023, then tumbled by 63.74% to $111898.0 in 2024, then jumped by 2150.53% to $2.5 million in 2025, then slumped by 86.41% to $342135.0 in 2026.
- Business Quant data shows NMTC's Share-based Compensation at $342135.0 in Q1 2026, $2.5 million in Q4 2025, and $358560.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neuroone Medical Technologies | 7.99 Mn | 5.19 Mn | 990,264.00 | 342,135.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 342,135.00 |
| Mar 31, 2026 | 342,135.00 |
| Dec 31, 2025 | 2.52 Mn |
| Dec 31, 2025 | 2.52 Mn |
| Sep 30, 2025 | 358,560.00 |
| Sep 30, 2025 | 358,560.00 |
| Jun 30, 2025 | 316,654.00 |
| Jun 30, 2025 | 316,654.00 |
| Mar 31, 2025 | 250,170.00 |
| Mar 31, 2025 | 250,170.00 |
| Dec 31, 2024 | 111,898.00 |
| Dec 31, 2024 | 111,898.00 |
| Sep 30, 2024 | 340,371.00 |
| Sep 30, 2024 | 340,371.00 |
| Jun 30, 2024 | 338,609.00 |
| Jun 30, 2024 | 338,609.00 |
| Mar 31, 2024 | 356,858.00 |
| Mar 31, 2024 | 356,858.00 |
| Dec 31, 2023 | 308,638.00 |
| Dec 31, 2023 | 308,638.00 |